Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

which includes low- and mid-scale oligo synthesis scales, at TIDES USA, taking place May 19–22 in San Diego. “Oligonucleotides are uniquely positioned to address diseases at their genetic root.

"The North American market is projected to grow at the highest CAGR during the Forecast" Oligonucleotide Synthesis Market Size by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents ...

From bench to bulk, pharma customers in the US and Canada will benefit from the latest solvent innovations and technologies ...

cGMP-compliant production of oligonucleotide APIs for clinical and commercial applications. CDMOs equipped with advanced solid-phase synthesis platforms, high-throughput purification technologies ...

A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital ...

An oxidation step creates a more stable coupling. The oligonucleotide is ready for another round of synthesis. (4) Chemicals stabilize coupling. Once the oligonucleotide reaches the desired length, ...

The partnership between Asahi Kasei Bioprocess America and PeptiSystems will extend globally across all relevant markets, ...

which includes low- and mid-scale oligo synthesis scales, at TIDES USA, taking place May 19–22 in San Diego. Oligo Factory has also strengthened its leadership team with the appointments of Luke ...